Caprolactam Chemicals Ltd. has announced the closure of its trading window effective October 1, 2026. This restriction applies to designated persons and will remain in force until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.

The move is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and BSE Circular No. List/Comp/01/2019-20 dated April 2, 2019. The company has formally intimated all designated persons that they must refrain from dealing in the company's securities during this period.

Regulatory compliance and timeline

The closure of the trading window is a standard procedural step to prevent insider trading while sensitive financial information is being compiled and reviewed. The specific period of restriction begins on October 1, 2026, and ends only after the public disclosure of the results.

Board meeting schedule

The date for the board meeting to approve and declare the financial results for the quarter and half year ended September 30, 2026, has not yet been finalized. The company stated that the board meeting date will be intimated in due course. Until then, the trading restrictions remain strictly enforced for all designated persons as defined under the regulatory framework.

Caprolactam Chemicals Limited posted a full-year net profit of ₹176.12 lakh for FY26, reversing a loss of ₹70.87 lakh recorded in the corresponding period of the previous year. The company’s revenue from operations more than doubled to ₹1,055.75 lakh, up from ₹673.96 lakh in FY25.

The 37th Annual General Meeting (AGM) is scheduled for September 28, 2026, to adopt the audited financial statements and approve key corporate actions. Shareholders holding shares as on the record date of September 21, 2026, will be eligible to vote via remote e-voting between September 24 and September 27, 2026.

Financial Performance

The company’s total income rose to ₹1,058.86 lakh from ₹674.92 lakh in the prior year. This growth was primarily driven by a surge in sale of services, which reached ₹1,028.69 lakh compared to ₹606.42 lakh previously. Sales of manufactured goods declined to ₹27.06 lakh from ₹67.54 lakh.

Total expenses increased to ₹842.29 lakh from ₹743.29 lakh. Finance costs rose to ₹71.91 lakh from ₹63.24 lakh, while depreciation and amortisation expenses decreased slightly to ₹161.41 lakh from ₹165.04 lakh. The company incurred a total tax expense of ₹40.44 lakh, comprising current tax of ₹37.35 lakh and deferred tax of ₹3.09 lakh.

Balance Sheet and Cash Flow

As of March 31, 2026, total assets stood at ₹1,703.96 lakh, up from ₹1,428.42 lakh. Current assets increased significantly to ₹657.13 lakh, driven by a rise in trade receivables to ₹621.18 lakh from ₹282.42 lakh. Inventories declined to ₹16.26 lakh from ₹40.65 lakh.

Short-term borrowings rose to ₹922.90 lakh from ₹871.34 lakh. The company maintained cash and cash equivalents of ₹8.69 lakh. Net cash generated from operating activities was ₹164.97 lakh, compared to an outflow of ₹56.18 lakh in the previous year.

Corporate Actions

The Board recommended the reappointment of Mrs. Zaver Shankarlal Bhanushali as Managing Director, who retires by rotation. Additionally, shareholders will vote to appoint M/s. Raman S. Shah & Co. as statutory auditors for a five-year term commencing from the conclusion of the AGM.

No dividend has been declared for FY26. The company’s paid-up equity share capital remains unchanged at ₹460 lakh, comprising 46 lakh equity shares of ₹10 each.